Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

ConditionOphthalmology
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20-85
SponsorNational Taiwan University Hospital

About this trial

Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.

Eligibility criteria

Qualifiers

None

Disqualifiers

Unable to answer the questions in the dry eye survey.

Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts.

Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect

Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin.

Trial design

Treatments tested in this trial

  • Systane COMPLETE

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators